List of Stem Cells Companies in India - 11

Advancells offers stem cells for various chronic conditions and lifestyle disorders.

Later part of the bygone twentieth century has witnessed a major revolution in the field of life-sciences. Researches carried out during this period, particularly in the area of molecular biology and recombinant technology, have led to emergence of 'Biotechnology'​ with a new face. Plants, animals and microorganisms being a key component of our ecosystem have always remained at centre-stage of research for different purposes as they affect the human life. Development of culture methods, better understanding about molecular biology, discovery of restriction endonucleases and their use in mapping of DNA laid the foundation stone for modern day biotechnology. Isolation of thermostable DNA polymerase along with the development of PCR technique made cloning simplified and providing way for rec-DNA technology. Further developments were generation of bar-code like DNA fragment patterns of genomic DNA. These patterns appeared useful in distinguishing individuals based on DNA sequence variations among them. Such variations of DNA among organisms were termed as fingerprints or profiles which provide a versatile tool to characterize genetic variability, genome evolution, population genetics, taxonomy, breeding and diagnostics even today! The technology to read the DNA base-by-base made it possible to identify useful genes. This information which could be cloned in suitable vectors and introduced in appropriate hosts through a variety of gene transfer methods gave an impetus to genetic improvement programmes and production of Genetically modified organisms. Today the genomic sequencing is contributing to identify the basis of pathology, providing tailored therapies. We are quickly advancing towards the in situ engineering of the genomic information to achieve designer humanity. Bioheaven ventures into this space "Turning Human Needs into Careful Solutions"​..........

Century Pharmaceuticals Ltd is a privately held Pharmaceutical Company based out Vadodara, India. For more than 30 years, we have emerged as a respectable name in the industry. Our services include manufacturing APIs, facilities for contract manufacturing, Biotechnology research, API research, stability studies, and more.

CrisprBits was started by entrepreneurs and scientists with extensive industry and academic experience, including in the biological sciences. We have prior experience in developing diagnostic solutions, precision medicine and clinical-research solutions that are used by pharmaceutical and biotechnology companies in India and around the world. We are motivated by three guiding principles: using deep science to deliver high quality products; adhering to the highest ethical standards, including in the choice of products we offer; and developing an organization that draws exceptional individuals with diverse backgrounds and affinities. We have offices in Delhi and Bengaluru. Our lab is located in C-CAMP, a premier incubator for biotechnology innovation in Bengaluru.

EXSURE is an R & D-based startup and we are developing the next generation of exosome-based cancer therapeutics. We are developing a unique exosome-based chemotherapeutic drug-delivery platform that will facilitate precise and guided delivery of anti-cancer drugs (existing on the market) into tumor cells and relapse-causing cells (cancer stem cells) without abruptly harming the healthy cells. Our platform will reduce chemotoxicity and chances of cancer relapse in cancer patients. Currently, we are working with a breast cancer model. We have validated the efficiency and efficacy of our platform in vitro (in different breast cancer cell lines and derived cancer stem cells) and ex-vivo (primary cells & stem cells derived from chemo-naive clinical samples of breast tumor biopsies). We are yet to validate our platform in vivo (SCID mice). We have filed the patent for the formulation we are using to develop these bioengineered drug-loaded targeted exosomes and the methodology behind it (Final patent to be filed this month). We are providing outsourcing services including any type of cell-culture-based assays, exosome-based experimentations, and cancer stem cell-based assays.

Pandorum is a biotechnology company based out of the US and India, working in the field of Tissue Engineering and Regenerative Medicine. With its distinct synergy of life science, engineering and clinical competences, at Pandorum, we have developed a proprietary technology platform which combines therapeutic exosomes with anti-inflammatory, anti-fibrotic properties derived from clinical grade human stem cells and biomaterials with tissue-mimetic properties – to promote efficient regeneration of human tissues, such as cornea, liver and lung. Pandorum has been supported by a number of Govt. grants (BIG, SBIRI) and awards, and have raised funding from marquee investors and VCs. We are proud to have a world-class team of scientists, engineers, clinicians, and key opinion leaders deeply engaged in the product development and clinical translation. Pandorum's efforts towards clinical translation of its products have been supported by renowned medical Institutions such as, are Northwestern Medicine (Chicago, US), Medical University of South Carolina (Charleston, US) and Dr. Shroff’s Charity Eye Hospital (New Delhi, India). Pandorum is also proud to be an Endless Frontier Labs (EFL) start-up, NYU Stern School of Business, Life Sciences Cohort -2023. At Pandorum our efforts are dedicated to make Regenerative Medicine an efficacious and scalable mainstream reality, to be able to address the sufferings of millions across the globe affected by various diseases of unmet clinical needs

StemGenn Therapeutics is leading the research and Development of efficient and affordable Cell Therapy ,Preventive & Personalized Functional Medicine for a wide range of Metabolic, Auto immune & Lifestyle conditions . StemGenn Aiming for Develop personalised Products for Cosmetic Gynecology, Infertility & Aesthetic Medicine. StemGenn Provides Personalized Care for Men’s Health for their Complete care from Skin, Diet to Sexual Health( Erectile Dysfunction). StemGenn Started exclusive Training Program to doctors , scientists and researchers for Regenerative Medicine, PRP, Cosmetic Gynecology( Vulvo-Vaginal Rejuvenation), Aesthetic Medicine, Laser, Radio Frequency and Bio-Revitalisation techniques first time in India . Stemgenn’s vision is to create a better and healthy world with cellular therapies and regenerative medicines. We aim at leveraging the benefits of stem cell therapy for anti-aging. Our core values consist of Caring, Safety, Excellence and Integrity for creating a healthy tomorrow."​ Mission: Contribute to human health by enabling technologies using Regenerative Medicine. Training programs are developed by our scientists and team of clinicians with the aim to overcome challenges in your experimental/ clinical procedures and advance your research and Therapeutics.We are Scientists Helping Scientists and doctors .Our highly interactive technical training is current with the latest tools and protocols, designed specifically for your needs. Contact : +91 9811011690, Email: contact@stemgenn.com

Stempeutics is a leading Regenerative Medicine company in Bangalore with our patented stem-cell therapy platform technology developing treatment of cardiovascular, immune-mediated and degenerative diseases. The company's flagship product, Stempeucel® has received market authorization to treat Critical Limb Ischemia – a major unmet medical need in India. It is the FIRST innovative cell therapy based product to get marketing approval in India and Globally. CIPLA, the Indian licensee, has commenced pan-India commercialization. It has the FIRST DCGI approved Cell therapy product for Knee Osteoarthritis being marketed by Alkem. Stempeutics has a product in the Phase 3 stage covering Diabetic Foot Ulcer. Further it is conducting Phase 2 trial in Perianal fistula due to Crohn’s disease. Stempeucel® has strong patent protection with 20 patents granted including US, Europe and Japan. Stempeucel® has been classified as an Advanced Therapy Medicinal Product (ATMP) and designated as an Orphan Drug for the treatment of CLI due to Buerger’s Disease by the European Medicines Agency (EMA) Another portfolio developed by Stempeutics is Stempeucare® range of cosmetics. It is developed from the stem cell derived Growth Factors/Cytokines combination for various cosmetic and derma applications including rejuvenation of aging skin, hair fall control & hair growth promotion, under eye dark circle reduction cream etc. First product which has gone to the market is an intensive firming skin care cosmetic product, branded as Cutisera™. Other products ready for marketing are Trichosera™ for Hair application and Optisera™ for under eye application With a strong pipeline in Cell and Gene therapy products in some of the largest health and personal care segments like OTC Cosmetics (Skin and Hair Care), Osteoarthritis, Diabetes, CLI and PAF Stempeutics is poised to transform the Cell & Gene therapy space with its India First, Global Next approach.

Transcell Biologics is an innovative biotech company with continuous discovery and process development as it's central theme to deliver unique disruptive stem cell based solutions to treat chronic and debilitating diseases that have otherwise no options available to manage. The passionate leadership team is committed to developing therapies to address important medical needs through adult stem cell technologies by collaborating with clinicians and patient communities. Among the company's landmark innovations is the development of a novel proprietary process for maximizing the therapeutic stem cell yield that also maintains the native pluripotent properties and inherent functionality. The Company has evolved from solely an R&D-focused biotech entity diversifying based on the intended applications of stem cell technologies.

Vopec Pharmaceuticals Private Ltd. is a pioneering company which is manufacturing Ayurveda and siddha formulations, and was established in the year 1996. Vopec pharma has taken up a leading role in the formulations re-establishing ancient knowledge with modern Research and manufacturing techniques. The company is located in Aminjikarai, Chennai having GMP Certificate and FSSA licence to manufacture nutraceuticals. Vopec also have licence to manufacture Ayurvedic and Siddha formulations including Sasthric products and Food supplements. Vopec is a stake holder in Traditional Ayush Cluster of Tamilnadu (P) Ltd., precisely called TACT. Vopec Pharmaceuticals has various herbal capsules, syrups and pain relieving oils like Nart Capsule, Asmask Capsules, Dyzee Syrup etc. Another exciting program that Vopec provides are the consultation slots with Ayurveda experts, where one can mention their problems or issues and get effective solutions within minutes.